relative to treatment alternatives to opioids.

HB 241 addresses opioid treatment alternatives, focusing on expanding access to non-opioid pain management options. The bill aims to directly affect patients with chronic pain and healthcare providers by establishing new guidelines for treatment referrals. Key provisions include requiring health insurers to cover FDA-approved non-opioid alternatives and creating a state-funded pilot program for community health centers to implement these alternatives. The committee report (10/28/2025, 17-0) recommended passage with an amendment, but the bill's specific mechanisms beyond these general requirements are not detailed in the provided context.